key: cord-0778300-ffae964y
authors: CHEN, Juliet Honglei; TONG, Kwok Kit; SU, Xiaoyu; YU, Eilo Wing-yat; WU, Anise M.S.
title: Measuring COVID-19 related anxiety and obsession: Validation of the COVID-19 Anxiety Scale and the Obsession with Coronavirus Scale in a probability Chinese sample
date: 2021-09-03
journal: J Affect Disord
DOI: 10.1016/j.jad.2021.08.104
sha: c9503525be264dcc453351166839ae15a174aee4
doc_id: 778300
cord_uid: ffae964y

BACKGROUND: With concern over the rise in mental health symptoms associated with the COVID-19 pandemic, the present study set out to address the absence of pandemic-specific screening tools for detecting those in Chinese societies who are at-risk for experiencing mental distress due to the pandemic; thus, its aim was to validate the Coronavirus Anxiety Scale (CAS) and Obsession with Coronavirus Scale (OCS) in Chinese adults. METHODS: With a two-stage cluster random sampling method, we surveyed 1,011 Chinese community-dwelling adults (38.8% men; 41.2 years old on average with an SD of 15.8) in June and July of 2020. RESULTS: Our psychometric evaluation results showed that the Chinese version of CAS and OCS retained their original one-dimensional structure and demonstrated measurement invariance across genders. In line with validation studies of the CAS and OCS in other languages, subsequent analyses also provided support to our Chinese version with respect to their satisfactory internal consistency (α = .87 and .73), respectively, and good concurrent validity (i.e., positive associations with negative feelings, excessive time-consumption, subjective distress, and functioning impairment). LIMITATIONS: Due to constraints of time and cross-sectional design, we only validated CAS and OCS among Chinese adults and did not evaluate their test-retest reliability nor predictive validity. CONCLUSIONS: Considering the practical benefits of understanding the source of mental symptoms during the pandemic, we recommend the use of CAS and OCS in Chinese communities to facilitate early identification and intervention for those who require clinical attention due to their COVID-19 related anxiety and obsessive thoughts.

Since the end of 2019, the newly discovered coronavirus SARS-CoV-2, which can cause coronavirus disease , has quickly developed into one of the deadliest pandemics in the 21st century, with a global death toll of over 2.7 million as of March 2021 (World Health Organization [WHO] , 2021). The emergence of symptoms of anxiety and obsessive thoughts as epidemics and pandemics breakout and progress has been welldocumented with respect to other public health crises (e.g., Blakey et al., 2015; Brand et al., 2013; Xie et al., 2011) . In a manner similar to responses to other crises, such as severe acute respiratory syndrome (SARS; T. W. Wong et al., 2007) and the swine flu (Rubin et al., 2009 ), various groups have experienced heightened levels of anxiety and related symptoms during the COVID-19 pandemic (e.g., E. P. H. González-Sanguino et al., 2020; Huang & Zhao, 2020) . A reasonable level of anxiety and cognitive arousal, which are evoked by the pandemic, may enhance one's level of awareness concerning the need to protect oneself from the virus and can help lower one's susceptibility to infection; however, excessive amounts of anxiety and obsessive thoughts tend to bring about psychosomatic symptoms and eventually lead to mental disorders (Taylor, 2019) . Because the impact to mental wellbeing brought by pandemics tends to be pervasive, long-lasting, and most likely occurs in several waves (Taylor, 2019) , regular screening throughout the pandemic and even beyond for maladaptive anxiety and obsessive thoughts in communities are greatly needed.

Whereas extant findings (e.g., E. P. H. González-Sanguino et al., 2020; Huang & Zhao, 2020) have substantiated the need to screen for anxiety and related symptoms during the COVID-19 pandemic, they have also exposed one shared drawbackthe inability to differentiate anxiety and associated symptoms that are directly related to the pandemic from those that are not. For example, all of the recent studies on pandemic-related anxiety in Chinese societies have adopted generalized assessment tools, such as the Generalized Anxiety Disorder Scale (GAD-7; e.g., E. P. H. Huang & Zhao, 2020) , the State-Trait Anxiety Inventory (STAI; e.g., Lin et al., 2020; L. P. Wong et al., 2020) and the Depression, Anxiety, and Stress Scale (DASS-21; e.g., J. H. Chen et al., 2021; , instead of pandemic-specific tools, to measure individuals' anxiety level. Although these scales are common and valid instruments in evaluating anxiety levels in general, they are unable to identify the possible origins of anxiety-related symptoms; that is, symptoms directly triggered by thinking or being exposed to coronavirus-related information (i.e., COVID-19 anxiety) versus symptoms elicited by lifestyle changes (e.g., social distancing) indirectly associated with the COVID-19 pandemic (i.e., the general anxiety). A significant difference between the COVID-19 related anxiety and the general anxiety lies in that the former comprises broader but specific, excessive worries about coronavirus, which include but are not limited to a morbid preoccupation about getting infected with COVID-19 (i.e., COVID-19 health anxiety; Tyrer, 2020) and a generalized, dysfunctional fear of COVID-19 (i.e., coronaphobia; Asmundson & Taylor, 2020) ; in contrast, the latter only entails generalized anticipation of a future threat (American Psychiatric Association [APA], 2013). The development of the general anxiety is more likely to be related to disorders under the DSM-5 anxiety disorders; while the COVID-19 anxiety may be associated with disorders not only under the DSM-5 anxiety disorders but also under somatic symptoms and related disorders (e.g., illness anxiety disorder) and trauma-and stress-related disorders. Failure to differentiate the sources of anxiety and related symptoms linked with COVID-19 might hinder an accurate diagnosis, delay the process of effective intervention, and eventually lead to individuals developing more serious mental disorders, such as posttraumatic stress disorder, obsessive and compulsive disorder, illness anxiety disorder, or generalized anxiety disorder.

Unlike those generalized scales, pandemic-specific screening tools can reveal a clearer picture of the direct impact on the mental health of the pandemic. For example, the specific scales developed for AIDS (Snell & Finney, 1998) and the swine flu (Wheaton et al., 2012) were able to provide more precise identification of potential causes of mental symptoms during each epidemic or pandemic wave and to inform health professionals and policy-makers of a more cost-effective approach to prevention and intervention planning that targeted the core source(s) of the problem. Furthermore, in screening symptoms with disease/situation-based scales, clinicians can attend to idiosyncrasies that might be at play under unusual circumstances and thus are able to overcome the limitations of generalized tools (for a discussion, see Sarason, 1978) . Therefore, devising and validating specific measurement tools for COVID-19 related mental symptoms may facilitate the efficiency of health professionals in targeting the source of the distress and hence safeguard the public's mental health in general.

In response to the COVID-19 global outbreak, Lee (2020b, 2020c) developed two short, specialized assessment tools, the Coronavirus Anxiety Scale (CAS) and the Obsession with Coronavirus Scale (OCS), to screen for COVID-19 induced mental distress that may need clinical attention. The CAS is a 5-item self-report screen for identifying people who might suffer from an unhealthy degree of anxiety due to the COVID-19 pandemic, which mainly entails behavioral and physiological reactions of elevated fear and excessive worry about coronavirus and its related stimuli (Lee, 2020a (Lee, , 2020c . It has an optimal cutoff score of ≥ 9, which corresponds to 90% sensitivity and 85% specificity (Lee, 2020c), and has demonstrated satisfactory reliability and validity initially in an American adult sample (N = 775; Lee, 2020c) and subsequently in various other ethnic samples, such as in South Koreans (E. , Portuguese (Magano et al., 2021), and Turks (Evren et al., 2020) . To date, the CAS has been included in the World Psychiatry Association's COVID-19 Mental Health Care Toolkit for quick screening for COVID-19 related anxiety at the primary care level (Adiukwu et al., 2020) . The 4-item OCS was developed for discerning maladaptive thinking about COVID-19, which approximately means spending at least three to seven days in a two-week time-frame on dreaming and repetitively thinking about the coronavirus and having disturbing thoughts that one has caught the coronavirus and that one saw particular people who may have the coronavirus (Lee, 2020b). Its optimal cutoff score was proposed as ≥ 7, indicating 81-93% sensitivity and 73-75% specificity. Its solid reliability and validity were found in the two American adult samples initially used for scale development (Lee, 2020b) and were later confirmed in several other samples with its different language versions (e.g., Andrade et al., 2021; Ashraf et al., 2020; . Nevertheless, to date, a Chinese validation of Lee's CAS and OCS is not yet available.

The present study aimed to address the lack of specialized scales for assessing 

We designed a telephone survey with a two-stage cluster random sampling method to acquire a probability sample of local residents in Macao, China. The inclusion criteria were male and female local adults (18 years old or above), with the ability to understand and speak Cantonese or Mandarin Chinese. In the first-stage of sampling, we randomly selected local households from the recent Macao residential phonebook as clusters. For households with more than one eligible respondent, the second-stage of random sampling was performed using the last-birthday rule (Gaziano, 2008) , in which the individual who most recently had his or her birthday was invited to participate in the survey voluntarily. The selected respondents received a briefing by trained research assistants on the nature of the study and their rights as research participants; there were no monetary incentives. The formal survey was administrated to only those who explicitly gave us oral consent to participate. Ethical approval of this study was acquired from the affiliated university of the corresponding author.

During late June and early July of 2020, we successfully interviewed 1011 respondents, which represented a cooperation rate of 80.6% (i.e., the percentage of all cases interviewed versus all eligible respondents ever contacted) according to the calculation method advised by the American Association for Public Opinion Research (2016). There were 38.8% men (95% CI [35.8%, 41.8%]) and 61.2% women (95% CI [58.2%, 64.2%]) whose average age was 41.2 years (SD = 15.8; range = 18 to 94). The majority of the respondents received education at tertiary (50.2%), senior high (28.2%), or junior high (12.5%) levels, while only a small portion were educated at the primary school (6.6%) or no formal education levels (1.7%). No respondents had a history of COVID-19 infection, and only 12 respondents (1.2%) reported knowing friend(s) or relative(s) who had been infected by COVID-19.

The Chinese version of CAS and OCS was developed in three stages. First, Lee's CAS and OCS (2020b, 2020c) were translated to Chinese and then back-translated to English independently by two bilingual researchers. Second, minor inconsistencies between the translation and back-translation (e.g., whether to stress the "cold feeling" in addition to "being unable to move" for the translation of "frozen" for CAS Item C) were discussed and resolved with further consultation with a third bilingual psychologist. A preliminary Chinese version of these two scales was generated based on the three experts' unanimous agreement.

Third, two additional psychologists independently evaluated the consistency between the translated Chinese version and the original English version and gave their endorsement to the translated version, which was subsequently finalized for use in the survey.

Consistent with the original English version, the Chinese version of 5-item CAS and 4-item OCS both adopted a 5-point Likert scale, ranging from 0 = not at all to 4 = nearly every day. The CAS captured information regarding how frequently respondents experienced COVID-19 anxiety in the past two weeks regarding behavioral and physiological symptoms (e.g., "I felt dizzy, lightheaded, or faint, when I read or listened to news about the coronavirus"). The OCS measured the frequency of persistent and disturbing thinking about COVID-19 (e.g., "I had disturbing thoughts that I may have caught the coronavirus") during the previous two weeks.

The 6-item negative feelings subscale of the Chinese version of Diener et al.'s (2010) scale of positive and negative experience (Tong & Wang, 2017) was used to assess respondents' negative feelings, such as unpleasant, sad, and afraid, during the past four weeks, on a 5-point Likert scale, which ranged from 1 = very rarely or never to 5 = very often of always. A sample question is: "How much have you experienced the feeling of being afraid in the past four weeks?" A summative score of the six items was computed to reflect the extent of one's experience of negative feelings in the recent month. Higher scores represented greater degrees of negative feeling. Cronbach's alpha of this subscale was .87 in the present study.

Three symptom severity indicators were included to evaluate potential adverse consequences associated with coronavirus anxiety and obsessive thinking: (a) excessive timeconsumption (i.e., "thinking about coronavirus related things have taken too much of my time"), (b) subjective distress (i.e., "thinking about coronavirus related things have caused me psychological distress"), and (c) functioning impairment (i.e., "thinking about coronavirus has affected my daily life and/or work"). Respondents were prompted to rate the frequency they had experienced the condition described in each indicator in the recent month on a 5point Likert scale, ranging from 1 = very rarely or never to 5 = very often of always. Each indicator was treated separately in the subsequent analyses. Higher indicator scores represented greater levels of symptom severity.

Respondents were requested to provide information on gender, age, and educational attainment (i.e., six levels from no formal education to tertiary education with a bachelor's degree or above). Additionally, respondents were asked whether they and their family and friends had ever been infected by COVID-19 (1 = yes, 0 = no).

We first employed descriptive statistics to provide a profile of the sample's demographic and psychological characteristics. Psychometric evaluation of the two measures began with a series of item analyses on each item of CAS and OCS, including the endorsement rate on the response scale, corrected-total correlation, squared-multiple correlation, and Cronbach's alpha if the item was deleted. Subsequently, we assessed the model fit of the original one-factor structure of CAS and OCS to the data independently with confirmatory factor analysis (CFA). A model was considered to be acceptable if it met the following criteria: (a) a comparative fit index (CFI) ≥ .90 and a Tucker-Lewis fit index (TLI) ≥ .90 (Hu & Bentler, 1999) , (b) a root mean square error of approximation (RMSEA) ≤ .08, and a standardized root mean square residual (SRMR) ≤ .08 (Browne & Cudeck, 1992; Hu & Bentler, 1999) . Further CFA testing was performed to examine the model's invariance across both genders on configural, metric, and scalar levels for CAS and OCS, respectively. The corresponding level of measurement invariance was defined as an acceptable model fit with a nonsignificant χ 2 difference test (p > .05; Vandenberg & Lance, 2000) . Using bivariate correlation analysis, the concurrent validity of CAS and OCS was then evaluated by testing their hypothesized positive associations with negative feelings and three symptom severity indicators. Additional non-parametric analyses were performed to explore the potential differences between high and low COVID-19 anxiety/obsession groups to examine the Table 1 Table   1 , the item factor loadings were statistically significant and ranged from .72 to .79 for CAS and from .48 to .90 for OCS. Most of these factor loadings were greater than the good rule of thumb of .50 or higher and ideally .70 or higher proposed by Hair et al. (2014) . Although two OCS items (i.e., items c and d) only presented a relatively lower factor loading of .48 and .50, we followed Knekta et al.'s (2019) suggestions and retained these two items for their essential contribution to the OCS construct as core diagnostic criteria. Given the confirmed unidimensionality of the two scales, the internal consistency of the 5-item CAS and the 4item OCS was also satisfactory, with Cronbach's alphas of .87 and .73, respectively.

[Insert Table 1 about here] Table 2 shows that the invariance model fit the data of male and female respondents well for both CAS and OCS at configural, metric, and scalar levels (CAS: CFI = .961 to .967, TLI = .914 to .967, RMSEA = .054 to .071, SRMR = .023 to .038; OCS: CFI = .983 to .995, TLI = .948 to .994, RMSEA = .023 to .068, SRMR = .023 to .025). By comparing the metric model with the configural model, we found scaled Δχ 2 (4) = 5.37, p = .25 for CAS and Δχ 2 (3) = 0.83, p = .84 for OCS, which indicated they both met the metric invariance criteria. The scalar invariance also held for both CAS (scaled Δχ 2 (4) = 3.61, p = .46) and OCS (scaled Δχ 2 (3) = 0.24, p = .97). To conclude, our findings supported that factor loadings and measurement intercepts were equal across genders for both CAS and OCS.

[Insert Table 2 

As presented in Table 3 , the concurrent validity of CAS was supported by its significant, positive association with negative feelings, excessive time-consumption, subjective distress, and functional impairment, with a mild-to-strong effect size (r = .27, .43, .52, .42, respectively; p < .001). Similarly, OCS had significant moderate-to-strong correlations with negative feelings, excessive time-consumption, subjective distress, and functioning impairment (r = .36, .56, .55, .47, respectively; p < .001). As expected, a strong, positive association between CAS and OCS (r = .55, p < .001) was also found.

When applying the criteria for an optimal cutoff score of ≥ 9 for CAS and ≥ 7 for OCS proposed by Lee (2020b, 2020c), we estimated 4.0% of our respondents reported scores in keeping with excessive levels of coronavirus anxiety (i.e., high COVID-19 anxiety group), whereas 10.5% reported excessive levels of obsession with coronavirus (i.e., high COVID-19 obsession group). Furthermore, we explored potential differences between high and low COVID-19 anxiety/obsession groups (based on the cutoff scores of CAS and OCS), respectively, regarding demographic features and endorsement on negative feelings and three symptom severity indicators. By comparing high and low COVID-19 anxiety groups, we did not observe a significant difference in gender (χ 2 (1) = 0.25, p = . 

The purpose of the present study was to validate a Chinese version of two coronavirus-specific mental health assessment tools, CAS and OCS, with a probability sample of Chinese adults; its two-stage cluster random sampling approach increased the generalizability of the findings to the target adult population. Our results supported the one-dimensional factor structure of CAS and OCS initially proposed by Lee (2020b, 2020c), which indicates one latent construct from the six CAS items and the four OCS items, respectively. Consistent with previous findings from studies that validated these instruments in various languages, our findings lent extra support to the cross-cultural universality of the one-dimensionality of the structure of CAS and OCS, in line with the Bangla (Ahmed et al., 2020) , Korean (E. , Portuguese (Magano et al., 2021) (Andrade et al., 2021) . Follow-up studies are warranted to explore further these two items' contributions to the latent construct of obsession with coronavirus across various regions and/or different courses as the COVID-19 pandemic develops. Furthermore, we found measurement invariance across genders for both CAS and OCS with our data at a scalar level. Not all researchers have tested for the gender invariance of CAS and OCS in the psychometric property evaluation of the two (e.g., E. , while those who did have reported a robust gender invariance finding for CAS (Ahmed et al., 2020; Lee, 2020c) and OCS (Ashraf et al., 2020) , similar to ours. Because previous studies have not yet specified at which level the gender invariance was held, our findings have revealed a more comprehensive picture of the measurement invariance across genders in Chinese.

Along the lines of previous validation studies (e.g., E. Evren et al., 2020) , we confirmed good internal consistency of CAS and OCS in Chinese adults, with Cronbach's alphas of .87 and .73, respectively, with our data. Because previous studies have also reported an increase in psychological distress and other negative consequences with higher levels of disease-specific anxiety (e.g., Wheaton et al., 2012) , the significant, positive association of the Chinese version of CAS and OCS assessed symptoms with negative feelings, excessive time-consumption, subjective distress, and functioning impairment provided empirical evidence to the concurrent validity of CAS and OCS. Our findings were also consistent with those of existing studies on CAS and OCS, which unanimously showed associations between CAS and OCS scores and adverse health outcomes, such as negative feelings or symptoms of psychological distress in general (Ashraf et al., 2020; Khosravani et al., 2020) , worse quality of life (Andrade et al., 2021) , and impairment in functioning (E. Lee, 2020b) . These findings lend support to the CAS and OCS scores in their capacity to reliably indicate the level of maladaptive anxiety and compulsive thoughts regarding the COVID-19 epidemic.

Using the cutoff score proposed by Lee (2020b, 2020c), we identified 4.0% and 10.5% of the sampled respondents as cases that are at-risk for excessive mental distress due to coronavirus anxiety and obsession, respectively. As shown by our data, these at-risk cases reported significantly higher levels of negative feelings, excessive time-consumption, subjective distress, and functioning impairment than their counterparts, supporting the screening efficacy of this cutoff score for Chinese. Using the identical cutoff scores of CAS ≥ 9 and OCS ≥ 7, cases showing excessive distress due to coronavirus anxiety and thinking of coronavirus were more prevalent in our Chinese community adult sample when compared to similar general population studies conducted in Korea (N = 329, 3.3% for anxiety and 5.5% for obsessions; , and Turkey (N = 763, 3.80% for anxiety; Yurttas et al., 2021) ; while an Indian general population study (N = 2004; Srivastava et al., 2020) reported a lower rate of CAS screened anxiety (i.e., 3.29%), but a higher rate of OCS screen obsessions (i.e., 13.47%) than ours. This difference in the prevalence of pandemic-specific anxiety may imply subtle stress response patterns across various ethnicities, pointing to a need for tailored prevention and intervention measures for people of different origins. By comparing at-risk case rates at general and pandemic-specific levels, we also detected a noticeable difference between the two in terms of a sizable higher rate of the former than the latter (e.g., 12.0% of probable generalized anxiety cases assessed by DASS-21 in J. H. Chen et al., 2020; versus 4 .0% of at-risk for coronavirus anxiety cases in our sample). These differences in prevalence rates indicate the need to differentiate the source of mental symptoms reported during the pandemic period and discern the pandemic-specific disordered cases from the general ones for targeted interventions. For example, in order to implement more cost-effective interventions, one may consider focusing more on coronavirus anxiety in women given their higher reported CAS scores than their male counterparts.

This study has three limitations. First, because of time restrictions of the phone survey, we did not measure the general anxiety and thus could not directly assess its association with the COVID-19 anxiety in our study. Admittedly, extant empirical studies have already established the distinctions between the general anxiety and the COVID-19 anxiety in terms of varying prevalence in the same sample (25.4% versus 36.0%, respectively; Lee et al., 2021) and a relatively high but not too high correlation coefficient (e.g., .75 among South Koreans and .57 among Brazilians; E. Padovan-Neto et al., 2021) ; however, it is still meaningful to explore how the two types of anxiety may interact with each other to shed light on tailed prevention and intervention strategies. Second, we only validated CAS and OCS among Chinese adults due to time constraints and limited resources. Given that pandemic-specific symptoms may also prevail in younger groups (e.g., F. Chen et al., 2020; Courtney et al., 2020) , we recommend that subsequent studies further adapt and test adolescent and children's versions of pandemic-specific mental health screening tools. Third, because of our cross-sectional design, we were unable to evaluate the test-retest reliability nor the predictive validity of CAS and OCS. Due to the inevitable fluctuations of mental symptoms during the pandemic (Taylor, 2019; Wang, Pan, Wan, Tan, Xu, McIntyre, et al., 2020) , longitudinal studies are warranted to track their changes over time.

To conclude, we validated CAS and OCS in a probability sample of Chinese community adults to address the need for pandemic-specific screening tools to assess for symptoms of psychological distress associated with the coronavirus in the Chinese context.

Our findings provided empirical support for both CAS and OCS to be reliable and valid measures for screening for coronavirus anxiety and obsession. The resultant tools not only allow for a quick screening for at-risk cases for excessive levels of anxiety and obsessions due to the COVID-19 pandemic, but also in identifying the degree and saliency of symptoms of such anxiety and obsessive thoughts among community-dwelling Chinese adults. As the impact of the COVID-19 pandemic tends to be prolonged and fluctuating in its intensity, we recommend the regular use of CAS and OCS in the community's mass screening for mental symptoms associated with coronavirus for early identification and intervention among Chinese in need. 0.50 *** Note. CAS = coronavirus anxiety scale, OCS = obsession with coronavirus scale, ITC = corrected item-total correlation, SMC = squared-multiple correlation, CID = Cronbach's alpha if item is deleted. *** p < .001. a The five-point response of CAS and OCS correspondents to 0 = Not at all, 1 = Rare, less than a day or two, 2 = several days, 3 = more than seven days, 4 = nearly nevery day over the last two weeks. b The goodness-of-fit indices for CAS was χ 2 (5) = 36.03, p < .001, CFI = .95, TLI = .90, RMSEA = .078, 90% CI [.056, .103], SRMR = .031; The goodness-of-fit indices for OCS was χ 2 (2) = 4.46, p = .11, CFI = .99, TLI = .99, RMSEA = .035, 90% CI [<.001, .079], SRMR = .015. .42 *** .47 *** .34 *** .49 *** .58 *** Note. CAS = coronavirus anxiety scale, OCS = obsession with coronavirus scale. *** p < .001.

COVID-19 mental health care toolkit: An international collaborative effort by Early Career Psychiatrists section

Adaptation of the Bangla Version of the COVID-19 Anxiety Scale

Diagnostic and statistical manual of mental disorders

Validation of the Brazilian Portuguese version of the Obsession with COVID-19 Scale

Factorial validity of the Urdu version of the Obsession with COVID-19 Scale: Preliminary investigation using a university sample in Pakistan

Coronaphobia: Fear and the 2019-nCoV outbreak

Alternative ways of assessing model fit

Depression and anxiety among adolescents during COVID-19: A cross-sectional study

Mental distress during the COVID-19 pandemic: Its association with public perceptions toward government's pandemic responses and lifestyle changes

Validation of the Korean version of the obsession with COVID-19 scale and the Coronavirus anxiety scale

Depression and Anxiety in Hong Kong during COVID-19

COVID-19 Impacts on Child and Youth Anxiety and Depression: Challenges and Opportunities

New Wellbeing Measures: Short Scales to Assess Flourishing and Positive and Negative Feelings

Validation and Psychometric Properties of the Portuguese Version of the Coronavirus Anxiety Scale (CAS) and Fear of COVID-19 Scale (FCV-19S) and Associations with Travel, Tourism and Hospitality

Mplus user's guide

Brazilian Adaptation of the Coronavirus Anxiety Scale: A Psychometric Investigation of a Measure of Coronaphobia

Public perceptions, anxiety, and behaviour change in relation to the swine flu outbreak: Cross sectional telephone survey

The Test Anxiety Scale: Concept and research

Multidimensional AIDS anxiety questionnaire

Anxiety, obsession and fear from coronavirus in Indian population: A web-based study using COVID-19 specific

A Review and Synthesis of the Measurement Invariance Literature: Suggestions, Practices, and Recommendations for Organizational Research

Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General Population in China

A longitudinal study on the mental health of general population during the COVID-19 epidemic in China

Psychological Predictors of Anxiety in Response to the H1N1 (Swine Flu) Pandemic

Anxiety symptoms and preventive measures during the COVID-19 outbreak in Taiwan

Anxiety among university students during the SARS epidemic in Hong Kong

WHO Coronavirus (COVID-19) Dashboard (as of

The 'Typhoon Eye Effect': Determinants of distress during the SARS epidemic

Willingness to get the COVID-19 vaccine among patients with rheumatic diseases, healthcare workers and general population in Turkey: A web-based survey

None.

The authors declare no conflicts of interest. 

最近這兩個星期，請問你有多經常有以下這些經歷呢？請用 0-4 評分，0 = "完全沒有"，1 = "很少，少於 1-2 日"，2 = "有幾日"，3 = "多於一個星期"，4 = "幾乎每日"。 a. 當我讀到或聽到有關新型冠狀病毒的新聞時，我感到頭暈、頭昏眼花或昏厥。 b. 當我想到新型冠狀病毒時，我難以入睡或維持睡眠狀態。 c. 當我想到或接觸到有關新型冠狀病毒的資訊時，我身體感到麻痹或冰冷。 d. 當我想到或接觸到有關新型冠狀病毒的資訊時，我對吃東西失去了興致。 e. 當我想到或接觸到有關新型冠狀病毒的資訊時，我就感到噁心或胃部不適。

最近這兩個星期，請問你有多經常有以下這些經歷呢？請用 0-4 評分，0 = "完全沒有"，1 = "很少，少於 1-2 日"，2 = "有幾日"，3 = "多於一個星期"，4 = "幾乎每日"。 a. 我有不安地想過我可能已經感染了新型冠狀病毒。 b. 我有不安地想過我見過的人裡面可能有人已經感染了新型冠狀病毒。 c. 我沒有辦法不去想關於新型冠狀病毒的事情。 d. 我曾經夢到過關於新型冠狀病毒的事情。